Our website uses cookies to ensure the best browsing experience.
If you want more information about cookies and how to control the qualification
with the settings of the browser access our Cookie Policy.

Lameplast Group, a single point of reference from concept to the finished product: the advantages of a comprehensive service.

A multi-function group with nearly 40-year background experience, millions of containers manufactured for many among the most important brands in the pharmaceutical and cosmetics industry.

Lameplast Groupprovides worldwide complete, flexible and integrated services for manufacturing, filling and packaging of pharmaceutical products, medical devices as well as cosmetics, from the design of new containers to the finished product.

Lameplast was founded

The first single-dose plastic container in 5-piece-strip for ophtalmics

Lameplast buys C.O.C. Farmaceutici

the first "Packaging Oscar"

ISO Certification

The second "Packaging Oscar"

The first Worldstar Oscar for Lameplast

Another Worldstar Oscar for Lameplast

The Lameplastgroup born

A new Packaging Oscar

A new plant for production of cosmetics

LF of America is founded in USA

Lameplast acquires the whole of C.O.C. Farmaceutici

The Pentafill brand is launched

Lameplast acquires 100% of LF of America

C.O.C. Health & Beauty Division born

The new manufacturing plant

Ready to start again

Multidose bottle without preservatives

A complete line of medical device for distribution

1976

1980

1990

1993

1995

1996

1997

2001

2002

2003

2004

2005

2008

2009

2011

2012

2013

2014

Play the Lameplast Group video

Companies

Lameplast SpA

Manufacturing of primary plastic containers for pharmaceuticals and cosmetics

It is overthirty-five years now that Lameplast has been closely collaborating with companies around the world to best satisfy the demanding requirements of innovative packaging solutions and new plastic materials. Each product developed by Lameplast is the result of advanced design capabilities, the use of state-of-the art technology and a thorough knowledge of the production and transformation processes of all types of plastic material. Lameplast can guarantees the highest possible quality standards at all times: all manufacturing process are carried out in a controlled contamination environment according ISO 7 (ex class 10.000) and ISO 8 (ex class 100.000) - ISO standard 14644-1, while rigorous tests and inspections are carried out Lameplast’s Quality Control Department on the entire manufacturing line. Lameplast’s Quality System has been certified according to UNI EN ISO 9001 Standard since 1995. The company is the holder of CE mark for Class I Medical Devices.

COC Farmaceutici processes pharmaceuticals under permit by the Italian Ministry of Health and according to European GMP and ISO Standards. COC Farmaceutici holds all due permits for the production ofpharmaceutical products for human and veterinary use as well as medical devices, for sterile and non-sterile liquid products, in single-dose or multi-dose primary containers. it is also authorized to process high activity active ingredients.

COC Farmaceutici HEALTH & BEAUTY Division guarantees the highest standards of safety in the preparation and packaging of cosmetic products, healthcare and non sterile medical devices offering an exclusive service for manufacturing, filling and packaging of liquid products, gels and creams in single-dose and multi-dose plastic containers and can explore and develop new packaging projects. Production site certified according to ISO 13485 for the manufacturing of non sterile medical devices and by Ecocert Italia for filling and packaging of organics and natural cosmetics.

LF of America is the LameplastGroup US subsidiary offering turn-key solutions to the Personal Care industry. LF of America clearly exemplifies the commitment of the LameplastGroup to be present in domestic and international markets, providing quality packaging, maximum flexibility, high production capacity and a complete range of integrated services: from formulation to product manufacturing and contract filling in Lameplast unit dose packaging.